Target intelligence / Profile preview

L-arabinitol dehydrogenase (Neurospora crassa) (NcLAD)

Target
NcLAD
Molecular classification
Enzyme, Oxidoreductase, Medium-chain dehydrogenase/reductase (MDR) family, Zinc-binding protein
01

Overview

Zinc-dependent dehydrogenase NcLAD, specifically known as L-arabinitol dehydrogenase from the filamentous fungus Neurospora crassa, is a key enzyme in the fungal pentose catabolic pathway (UniProt Q7S9L8). It catalyzes the NAD+-dependent oxidation of L-arabinitol to L-xylulose, which is a critical step for the utilization of L-arabinose as a carbon source (Nocek et al., 2011). Structurally, NcLAD belongs to the medium-chain dehydrogenase/reductase (MDR) family and requires a zinc ion for its catalytic activity. While not a primary therapeutic target for human diseases, NcLAD is of significant interest in industrial biotechnology and metabolic engineering for the production of biofuels and biochemicals from lignocellulosic biomass. Its well-characterized structure and kinetics make it a model for understanding polyol metabolism in fungi. The enzyme's specificity and efficiency are key factors in designing microbial cell factories for sustainable chemical production.

Other names
L-arabinitol 4-dehydrogenaseLAD-1NCU00643Zinc-dependent L-arabinitol dehydrogenase
02

Mechanism of action

Catalyzes the NAD+-dependent oxidation of L-arabinitol to L-xylulose.

03

Biological functions

Pentose catabolismL-arabinitol metabolismCarbohydrate metabolic process

Beyond the preview

Go deeper on L-arabinitol dehydrogenase (Neurospora crassa) (NcLAD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-arabinitol dehydrogenase (Neurospora crassa) (NcLAD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call